There was only a total of 58 cases in 2023.
There have been 41 cases of measles in the U.S. this year, according to the weekly update by the Centers for Disease Control and Prevention.
The report from Feb. 29 states that cases have been reported in Arizona, California, Florida, Georgia, Indiana, Louisiana, Maryland, Michigan, Minnesota, Missouri, New Jersey, New York City, Ohio, Pennsylvania, Virginia and Washington.
If this trend continues, this year’s numbers will soon surpass last year's – only 58 measles cases were reported for 2023. The biggest spike was seen during the week of Dec. 24 with 11 cases.
In 2020, there were only 13 cases reported, likely due to social distancing rules put in place during the COVID-19 pandemic.
The last large outbreak occurred in 2019, with a record 1,274 cases across 31 states, making it the highest number since 1992.
Measles (rubeola) is a highly contagious respiratory virus that has the potential to become deadly. It is still one of the most common respiratory diseases in the world, but thanks to vaccines, numbers in the United States have gone down tremendously. Before the first vaccine was developed in 1963, 3 to 4 million people in the U.S. got measles each year, according to the FDA.
Most people who get the most common two-dose version of the vaccine will never get the disease, even if they’ve been exposed. However, cases are on the rise due to a combination of the growing suspicion of vaccines and an increase in international travel.
2023 Drug Trend Report - Xevant
May 16th 2024To effectively navigate the changing pharmacy landscape and maintain a robust, cost-effective pharmacy benefit, you must understand the forces behind rising drug trend. What’s driving your costs and what can you do about it? As a leader in the PBM analytics space, we offer a unique perspective on pivotal trend drivers. Here’s what our comprehensive analysis revealed: -A surge in utilization rates across specialty and non-specialty drugs, magnified by anti-obesity therapies -Financial strain imposed by anti-inflammatory biologics and the yet-to-be-fulfilled -promise of biosimilar savings -Persistent price inflation driving higher costs year over year
Read More
2024 Emerging Leaders in Healthcare — Submit For a Chance to Be Featured in MHE's August Issue
May 14th 2024MHE Editors are seeking diverse healthcare professionals from different backgrounds and healthcare sectors, with individual interests. Eligible candidates are early or mid-career leaders with less than 10 years of experience. Award winners will enjoy complimentary passes to the PBMI Annual National Meeting in Orlando, Florida, from Sept. 4-6. Additional perks include a feature in our August issue, a subscription to MHE and more!
Read More